XML 113 R101.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Related Parties - Life Sciences Narrative (Details) - USD ($)
1 Months Ended 2 Months Ended 3 Months Ended
May 01, 2024
Apr. 30, 2024
Mar. 31, 2024
Mar. 31, 2024
Mar. 31, 2023
Jan. 31, 2024
Dec. 31, 2023
Related Party Transaction [Line Items]              
Accrued interest and exit fees     $ 9,100,000 $ 9,100,000     $ 17,100,000
Exit fee payable     15,900,000 15,900,000     15,900,000
Total Life Sciences segment revenue       315,200,000 $ 317,900,000    
Related receivables from this subsidiary     100,000 100,000     0
Share-based compensation expense       400,000 500,000    
Life Sciences | R2 Technologies | Related Party              
Related Party Transaction [Line Items]              
Interest cost relating to contractual interest coupon       900,000 500,000    
Accrued interest and exit fees     0 0      
Interest costs capitalized     700,000        
Face amount             2,400,000
Exit fee payable     2,200,000 2,200,000      
Total Life Sciences segment revenue       200,000      
Share-based compensation expense       100,000 100,000    
Life Sciences              
Related Party Transaction [Line Items]              
Total Life Sciences segment revenue       1,000,000.0 $ 500,000    
Life Sciences | R2 Technologies | Related Party              
Related Party Transaction [Line Items]              
Accrued interest and exit fees           $ 2,600,000  
Face amount           $ 20,000,000  
Life Sciences | R2 Technologies | Related Party | Subsequent Event              
Related Party Transaction [Line Items]              
Exit fee (as a percent) 10.71% 10.50%          
20.00% Note due 2024 | Life Sciences              
Related Party Transaction [Line Items]              
Short-term debt     $ 20,700,000 $ 20,700,000     $ 17,400,000